bpc-157 dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Dosage Guide: Protocols &
Description
Snelson M, Tan SM, Higgins GC, Lindblom RSJ, Coughlan MT
Tip: Use desiccant packs in your freezer storage containers to reduce humidity exposure
A Stern Call to Action Your health is not an experiment
This takes an extra 10 seconds and preserves the integrity of your peptide
A dose increase and retest is the right next step
It resists degradation from light exposure, temperature fluctuations, and oxidation
